Xianghong Meng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xianghong Meng has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Bingjie Liu
State Key Laboratory of Marine Food Processing & Safety Control, College of Food Science and Engineering Ocean University of China Qingdao China
3 shared publications Fuyong Chen
Department of Neurosurgery, University of Hongkong Shenzhen Hospital, Shenzhen, China
2 shared publicationsAlzheimer’s Disease Neuroimaging Initiative
1 shared publication- Benchi Wang
Key Laboratory of Brain, Cognition and Education Sciences, South China Normal University, Ministry of Education, Guangzhou, China
1 shared publication - Bing‐Mei Li
Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and Ministry of Education of China, Second Affiliated Hospital Guangzhou Medical University Guangzhou China
1 shared publication - Debo Dong
Key Laboratory of Cognition and Personality, Ministry of Education, Faculty of Psychology, Southwest University, Chongqing, China
1 shared publication
Latest Publications
De novo SRCAP variants cause developmental and epileptic encephalopathy and the phenotypic spectrum
Objective: The SRCAP gene encodes a core catalytic subunit of adenosine triphosphate‐dependent chromatin remodeling complexes that play an essential role in chromatin regulation and neurodevelopment. Our recent study showed that the EP400 gene, the paralog of SRCAP , is associated with neurodevelopmental disorders and epilepsy. This study aims to explore the relationship between SRCAP and developmental and epileptic encephalopathy (DEE) and the phenotypic spectrum of SRCAP variants. Methods: Trio‐based whole‐exome sequencing was performed on patients with DEE from the China Epilepsy Gene 1.0 Project Cohort. Additional cases were screened from other subcohorts. The gene–disease association was validated by minor allele frequency (MAF), damaging effect of variants, genotype–phenotype correlation, and studies on spatial–temporal and single‐cell expression. Results: De novo heterozygous SRCAP variants were identified in five patients with DEE. These variants were truncations or missense variants of severe damage characterized by significant changes in hydrophobicity and protein stability/hydrogen bonding. Additional SRCAP variants were identified in six patients with focal epilepsy (FE), including refractory FE. These variants were characterized by biallelic variants of mild damage, such as in‐frame indel or missense with fewer changes in hydrophobicity and protein stability/hydrogen bonding, which were correlated with the severity of phenotype and outcomes. The epilepsy‐associated variants presented statistically lower MAF than benign variants, with the lowest MAF in DEE‐associated variants. Compared to EP400 , SRCAP presented higher expression in the brain throughout the lifespan. In the late developmental brain, EP400 is predominantly expressed in excitatory neurons, in contrast to the higher proportion of SRCAP expression in inhibitory neurons, explaining the association of SRCAP variants with DEE and refractory FE. Significance: SRCAP is associated with epilepsy and DEE. The phenotypic spectrum ranges from DEE/multisystem developmental disorders to FE of varied severity, depending on the damage of variants. The development‐dependent expression pattern of neuron specificity explains the underlying mechanism of epilepsy outcomes.
De novo SRCAP variants cause developmental and epileptic encephalopathy and the phenotypic spectrum
Objective: The SRCAP gene encodes a core catalytic subunit of adenosine triphosphate‐dependent chromatin remodeling complexes that play an essential role in chromatin regulation and neurodevelopment. Our recent study showed that the EP400 gene, the paralog of SRCAP , is associated with neurodevelopmental disorders and epilepsy. This study aims to explore the relationship between SRCAP and developmental and epileptic encephalopathy (DEE) and the phenotypic spectrum of SRCAP variants. Methods: Trio‐based whole‐exome sequencing was performed on patients with DEE from the China Epilepsy Gene 1.0 Project Cohort. Additional cases were screened from other subcohorts. The gene–disease association was validated by minor allele frequency (MAF), damaging effect of variants, genotype–phenotype correlation, and studies on spatial–temporal and single‐cell expression. Results: De novo heterozygous SRCAP variants were identified in five patients with DEE. These variants were truncations or missense variants of severe damage characterized by significant changes in hydrophobicity and protein stability/hydrogen bonding. Additional SRCAP variants were identified in six patients with focal epilepsy (FE), including refractory FE. These variants were characterized by biallelic variants of mild damage, such as in‐frame indel or missense with fewer changes in hydrophobicity and protein stability/hydrogen bonding, which were correlated with the severity of phenotype and outcomes. The epilepsy‐associated variants presented statistically lower MAF than benign variants, with the lowest MAF in DEE‐associated variants. Compared to EP400 , SRCAP presented higher expression in the brain throughout the lifespan. In the late developmental brain, EP400 is predominantly expressed in excitatory neurons, in contrast to the higher proportion of SRCAP expression in inhibitory neurons, explaining the association of SRCAP variants with DEE and refractory FE. Significance: SRCAP is associated with epilepsy and DEE. The phenotypic spectrum ranges from DEE/multisystem developmental disorders to FE of varied severity, depending on the damage of variants. The development‐dependent expression pattern of neuron specificity explains the underlying mechanism of epilepsy outcomes.
- 27 March 2024
- Published by Springer Nature in Nature Human Behaviour
- Vol. 8 (5) , 932-944
Neural evidence for attentional capture by salient distractors
Salient objects often capture our attention, serving as distractors and hindering our current goals. It remains unclear when and how salient distractors interact with our goals, and our knowledge on the neural mechanisms responsible for attentional capture is limited to a few brain regions recorded from non-human primates. Here we conducted a multivariate analysis on human intracranial signals covering most brain regions and successfully dissociated distractor-specific representations from target-arousal signals in the high-frequency (60–100 Hz) activity. We found that salient distractors were processed rapidly around 220 ms, while target-tuning attention was attenuated simultaneously, supporting initial capture by distractors. Notably, neuronal activity specific to the distractor representation was strongest in the superior and middle temporal gyrus, amygdala and anterior cingulate cortex, while there were smaller contributions from the parietal and frontal cortices. These results provide neural evidence for attentional capture by salient distractors engaging a much larger network than previously appreciated.
- 27 March 2024
- Published by Springer Nature in Nature Human Behaviour
- Vol. 8 (5) , 932-944
Neural evidence for attentional capture by salient distractors
Salient objects often capture our attention, serving as distractors and hindering our current goals. It remains unclear when and how salient distractors interact with our goals, and our knowledge on the neural mechanisms responsible for attentional capture is limited to a few brain regions recorded from non-human primates. Here we conducted a multivariate analysis on human intracranial signals covering most brain regions and successfully dissociated distractor-specific representations from target-arousal signals in the high-frequency (60–100 Hz) activity. We found that salient distractors were processed rapidly around 220 ms, while target-tuning attention was attenuated simultaneously, supporting initial capture by distractors. Notably, neuronal activity specific to the distractor representation was strongest in the superior and middle temporal gyrus, amygdala and anterior cingulate cortex, while there were smaller contributions from the parietal and frontal cortices. These results provide neural evidence for attentional capture by salient distractors engaging a much larger network than previously appreciated.
- Open Access
Distance-dependent reconfiguration of hubs in Alzheimer’s disease: a cross-tissue functional network study
The hubs of the intra-grey matter (GM) network were sensitive to anatomical distance and susceptible to neuropathological damage. However, few studies examined the hubs of cross-tissue distance-dependent networks and their changes in Alzheimer’s disease (AD). Using resting-state fMRI data of 30 AD patients and 37 normal older adults (NC), we constructed the cross-tissue networks based on functional connectivity (FC) between GM and white matter (WM) voxels. In the full-ranged and distance-dependent networks (characterized by gradually increased Euclidean distances between GM and WM voxels), their hubs were identified with weight degree metrics (frWD and ddWD). We compared these WD metrics between AD and NC; using the resultant abnormal WDs as the seeds, we performed seed-based FC analysis. With increasing distance, the GM hubs of distance-dependent networks moved from the medial to lateral cortices, and the WM hubs spread from the projection fibers to longitudinal fascicles. Abnormal ddWD metrics in AD were primarily located in the hubs of distance-dependent networks around 20-100mm. Decreased ddWDs were located in the left corona radiation (CR), which had decreased FCs with the executive network’s GM regions in AD. Increased ddWDs were located in the posterior thalamic radiation (PTR) and the temporal-parietal-occipital junction (TPO), and their FCs were larger in AD. Increased ddWDs were shown in the sagittal striatum, which had larger FCs with the salience network’s GM regions in AD. The reconfiguration of cross-tissue distance-dependent networks possibly reflected the disruption in the neural circuit of executive function and the compensatory changes in the neural circuits of visuospatial and social-emotional functions in AD.
Open AccessDistance-dependent reconfiguration of hubs in Alzheimer’s disease: a cross-tissue functional network study
The hubs of the intra-grey matter (GM) network were sensitive to anatomical distance and susceptible to neuropathological damage. However, few studies examined the hubs of cross-tissue distance-dependent networks and their changes in Alzheimer’s disease (AD). Using resting-state fMRI data of 30 AD patients and 37 normal older adults (NC), we constructed the cross-tissue networks based on functional connectivity (FC) between GM and white matter (WM) voxels. In the full-ranged and distance-dependent networks (characterized by gradually increased Euclidean distances between GM and WM voxels), their hubs were identified with weight degree metrics (frWD and ddWD). We compared these WD metrics between AD and NC; using the resultant abnormal WDs as the seeds, we performed seed-based FC analysis. With increasing distance, the GM hubs of distance-dependent networks moved from the medial to lateral cortices, and the WM hubs spread from the projection fibers to longitudinal fascicles. Abnormal ddWD metrics in AD were primarily located in the hubs of distance-dependent networks around 20-100mm. Decreased ddWDs were located in the left corona radiation (CR), which had decreased FCs with the executive network’s GM regions in AD. Increased ddWDs were located in the posterior thalamic radiation (PTR) and the temporal-parietal-occipital junction (TPO), and their FCs were larger in AD. Increased ddWDs were shown in the sagittal striatum, which had larger FCs with the salience network’s GM regions in AD. The reconfiguration of cross-tissue distance-dependent networks possibly reflected the disruption in the neural circuit of executive function and the compensatory changes in the neural circuits of visuospatial and social-emotional functions in AD.
- 8 November 2022
- Published by Springer Nature in Journal of Ocean University of China
- Vol. 21 (6) , 1649-1655
Removal of Arsenic from Chlamys farreri with Different Methods
- 8 November 2022
- Published by Springer Nature in Journal of Ocean University of China
- Vol. 21 (6) , 1649-1655
Removal of Arsenic from Chlamys farreri with Different Methods
- 19 October 2022
- Published by Elsevier in Food Chemistry
- Vol. 404 (Pt B) , 134664
Mechanisms and technology of marine oligosaccharides to control postharvest disease of fruits
- 19 October 2022
- Published by Elsevier in Food Chemistry
- Vol. 404 (Pt B) , 134664
Mechanisms and technology of marine oligosaccharides to control postharvest disease of fruits
- 1 August 2021
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 185, 782-791
Preparation, characterization of PLGA/chitosan nanoparticles as a delivery system for controlled release of DHA
- 1 August 2021
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 185, 782-791
Preparation, characterization of PLGA/chitosan nanoparticles as a delivery system for controlled release of DHA
- 10 June 2016
- Published by Taylor & Francis
- p. 271-316
Postharvest Treatments Affecting Storage Quality of Chinese Jujubes
- 10 June 2016
- Published by Taylor & Francis
- p. 271-316
Postharvest Treatments Affecting Storage Quality of Chinese Jujubes
- Open Access
- 1 March 2008
- Published by Wiley in The FASEB Journal
- Vol. 22 (S1) , 1238.5
Protective effect of curcumin against high glucose‐induced endoplasmic reticulum stress by downregulation of COX‐2 expression in human umbilical vein endothelial cells
OBJECTIVE: The aim of this study is to investigate whether curcumin could protect against high glucose‐induced apoptosis by suppressing endoplasmic reticulum (ER) stress pathway in human umbilical vein endothelial cells (HUVECs). METHODS: HUVECs were exposed to low glucose (5.5mmol/L) or high glucose (30mmol/L) for 12~48 h. The expression of ER stress‐related markers (glucose‐regulated protein 78 (GRP78/Bip) and CAAT/enhancer binding protein homologous protein (CHOP)) and cyclooxygenase‐2 (COX‐2) were also evaluated by western blotting analysis. RESULTS: (1) Annexin V‐FITC/PI flow cytometry analysis revealed a time‐dependent increase of apoptotic cells in HUVECs treated with high glucose. Curcumin (10~100 μ mol/L) inhibited the high glucose‐induced apoptosis in a dose‐denpendent manner. (2) High glucose induced a time‐dependent increase in the levels of COX‐2, GRP78 and CHOP proteins expression in HUVECs. (3) Curcumin and NS‐398 (a COX‐2 inhibitor) downregulated high glucose‐induced overexpression of COX‐2 and CHOP expression in HUVECs. CONCLUSION: These data suggest that curcumin can protect the HUVECs against high glucose‐induced apoptosis by downregulation of COX‐2 and inhibition of endoplasmic reticulum stress. (This work was supported by the National Natural Science Foundation of China (No. 30400094))
- 1 March 2008
- Published by Wiley in The FASEB Journal
- Vol. 22 (S1) , 1238.5
Open AccessProtective effect of curcumin against high glucose‐induced endoplasmic reticulum stress by downregulation of COX‐2 expression in human umbilical vein endothelial cells
OBJECTIVE: The aim of this study is to investigate whether curcumin could protect against high glucose‐induced apoptosis by suppressing endoplasmic reticulum (ER) stress pathway in human umbilical vein endothelial cells (HUVECs). METHODS: HUVECs were exposed to low glucose (5.5mmol/L) or high glucose (30mmol/L) for 12~48 h. The expression of ER stress‐related markers (glucose‐regulated protein 78 (GRP78/Bip) and CAAT/enhancer binding protein homologous protein (CHOP)) and cyclooxygenase‐2 (COX‐2) were also evaluated by western blotting analysis. RESULTS: (1) Annexin V‐FITC/PI flow cytometry analysis revealed a time‐dependent increase of apoptotic cells in HUVECs treated with high glucose. Curcumin (10~100 μ mol/L) inhibited the high glucose‐induced apoptosis in a dose‐denpendent manner. (2) High glucose induced a time‐dependent increase in the levels of COX‐2, GRP78 and CHOP proteins expression in HUVECs. (3) Curcumin and NS‐398 (a COX‐2 inhibitor) downregulated high glucose‐induced overexpression of COX‐2 and CHOP expression in HUVECs. CONCLUSION: These data suggest that curcumin can protect the HUVECs against high glucose‐induced apoptosis by downregulation of COX‐2 and inhibition of endoplasmic reticulum stress. (This work was supported by the National Natural Science Foundation of China (No. 30400094))